Remove 2020 Remove Labelling Remove Packaging
article thumbnail

Celebrating 25 Years of Pharmaceutical Packaging Experience

Pharma Packaging Solutions

Happy 2020! At Pharma Packaging Solutions, we are celebrating 25 years of pharmaceutical packaging experience and now we look forward to the next 25 years. We hope you will be part of our next 25 years and let us know how we can be of service with your primary and secondary solid dose pharmaceutical packaging.

article thumbnail

Can holograms help in the frontline fight against pharmaceutical counterfeiting?

European Pharmaceutical Review

Indeed, a 2020 operation coordinated by Europol across 27 countries led to the seizure of more than 25 million units of counterfeit anticancer drugs and erectile dysfunction medicines among other fake drugs worth nearly €73 million. One area in which the problem can be tackled effectively is product packaging.

Packaging 111
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Common pharma compliance concerns cited by FDA warning letters

European Pharmaceutical Review

A study of the causes of warning letters issued by the US Food and Drug Administration (FDA)’s Center for Drug Evaluation and Research (CDER) and Center for Devices and Radiological Health (CDRH) between 2010 and 2020 revealed that poor current good manufacturing practice (cGMP) compliance and misbranding were the most common citations.

article thumbnail

Domestic CPO Services If You Need US Based Production

Pharma Packaging Solutions

With unprecedented demand for products manufactured in the US and potential trade disruption challenges, we do offer our domestic contract packaging services as a backup. Hospital Unit Dose (HUD) Packaging. Low Humidity Packaging (we can hold 3% humidity in 70 degrees Fahrenheit). Vial labeling.

article thumbnail

Mallinckrodt’s long haul with terlipressin in US ends in approval

pharmaphorum

It had been held up in the US by compliance issues that forced Mallinckrodt to change its packaging and labelling manufacturing facility and resulted in the FDA rejecting its application in February.

article thumbnail

Health Canada consults on transition of interim order drugs, vaccines, and medical devices to permanent approval pathways

Pharma in Brief

continue to exclude COVID-19 drugs from brand-name assessments, including a look-alike/sound-alike assessment and labeling mock-ups, at the time of submitting an NDS. Consultation on the transition approach is open until December 21, 2020. Manufacturers would be required to provide bilingual labelling under certain circumstances.

article thumbnail

At Agilent, we believe that sustainability, productivity and efficiency can co-exist in a lab without compromising on ROI

Express Pharma

Whereas proper disposal of unused medications, as well as initiatives to reduce packaging waste, chemical waste, and improve recycling programmes, will aid in pro-actively addressing this challenge. This may involve the use of eco-friendly raw materials, green manufacturing processes, and eco-friendly packaging.